Our analyses show a high prevalence of MS in ELSA hypertensives , a substantial incidence of new cases of MS and diabetes , the latter mostly among patients with MS. These analyses also show that in ELSA lacidipine was superior to atenolol , not only in showing a lower progression of carotid atherosclerosis , but also in causing a significantly lower incidence of new MS.
